Oric Pharmaceuticals Inc

NASDAQ ORIC

Data sourced from iex and EODHD
Download Data

Oric Pharmaceuticals Inc Cash Flow Statement 2017 - 2023

This table shows the Cash Flow Statement for Oric Pharmaceuticals Inc going from 2017 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Net Income
M -101 -89 -79 -74 -27 -21 -22
Depreciation and Amortization
M 1 1 1 1 1 1 1
Non-Cash Items (Other)
M -3 -1 1 20 0 0 -
Operating Cash Flow
M -86 -75 -60 -45 -24 -21 -21
Capital Expenditures
M -1 -2 -1 -1 -1 -1 0
Net Acquisitions
M - - - - - - -
Other Investing Activities
M - - - 0 0 0 0
Investing Cash Flow
M - - - 0 0 0 0
Repayment/Issuance of Debt (Net)
M - - - - - - -
Equity Repurchase (Common, Net)
M - 1 51 272 71 38 -
Dividends Paid
M - - - - - - -
Other Financial Activities
M 0 0 -1 -21 0 38 0
Financing Cash Flow
M 0 0 -1 -21 0 38 0
Exchange Rate Adjustment
M - - - - - - -
Beginning Cash
M 67 226 78 89 43 26 -
Ending Cash
M 23 67 226 78 89 43 26
Stock-Based Compensation
M 15 14 13 5 1 0 -
Issuance/Purchase of Shares
M - 1 51 272 71 38 -
Capital Stock Change
M 85 25 50 271 71 38 -
Working Capital
M 192 195 225 288 85 41 24
Free Cash Flow
M -87 -77 -60 -46 -24 -21 -

StockViz Staff

September 20, 2024

Any question? Send us an email